MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0027850
Titan Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹332.25 Cr
Latest filing
Net profit · FY 2025
₹57.22 Cr
Net margin 17.2%
EBITDA · FY 2025
₹91.56 Cr
EBITDA margin 27.6%
Authorised capital
₹45 Cr
Registered with MCA
Paid-up capital
₹41.33 Cr
Issued & subscribed
Open charges
₹79.6 Cr
Satisfied ₹11.43 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
305
Provident fund records
About Titan Laboratories Private Limited
Data last updated:
Titan Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2004PTC146928. Its GSTIN is 27AACCT0509Q1Z2 (Maharashtra).
The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹41.33 Cr. It is led by directors Piyush Bhailal Shah (Managing Director) and Deepak Bhailal Shah (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹332.25 Cr. For the same year it recorded a net profit of ₹57.22 Cr (net margin 17.2%) and EBITDA of ₹91.56 Cr (EBITDA margin 27.6%).
The company has about 305 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Titan-Laboratories. As per MCA filings, the company has open charges of ₹79.6 Cr and satisfied charges of ₹11.43 Cr on record. Court records list 22 cases involving the company, including 8 filed by the company and 14 filed against it; 4 cases are pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹89.1 Lakh; the latest was in March 2024. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Geno Pharmaceuticals Private Limited with revenue of ₹349.47 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2023, listing 64 overdue payments to 48 micro and small suppliers.
Titan Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0027850). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website titan-lab.com.
Company details
CIN U24100MH2004PTC146928
Registration Number 146928
Incorporation Date 14 June 2004
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0027850
Recognitions & Rankings of Titan Laboratories
Contact details
Titan Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is titan-lab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA/01 – GF & A/101 Plot No.120 Anand Bhavan Spectrum Building R B Mehta Marg Tilak, Road, Mumbai, Maharashtra, India – 400077
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Titan Laboratories Private Limited, buy the company report.
Comprehensive company report
Titan Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Titan Laboratories operates one associated brand: Titan-Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Titan Laboratories is a contract manufacturer of active ingredients for nutraceuticals and pharmaceuticals. | titan-lab.com |
Business activity
The main business activity of Titan Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Titan Laboratories Private Limited, buy the company report.
Financials of Titan Laboratories Private Limited
FY 2025 filings availableTitan Laboratories Private Limited reported revenue of ₹332.25 Cr for FY 2025.
Revenue · FY 2025
₹332.25 Cr
Net profit · FY 2025
₹57.22 Cr margin 17.2%
EBITDA · FY 2025
₹91.56 Cr margin 27.6%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹91.56 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.6% | ||||
| Net Profit Margin | 17.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Titan Laboratories Private Limited, buy the company report.
Board of directors of Titan Laboratories Private Limited
Titan Laboratories has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Bhailal Shah | Whole-Time Director | 01 Apr 2008 | 18 Years 6 Months | Current |
| Piyush Bhailal Shah | Managing Director | 14 Jun 2004 | 22 Years 4 Months | Current |
Peer comparison
Titan Laboratories Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Geno Pharmaceuticals Private Limited | ₹349.47 Cr (FY 2025) | 14.0% | Goa, India | |||
| Sparsh Bio-Tech Private Limited | ₹346.49 Cr (FY 2025) | -29.0% | Jamnagar, Gujarat, India | |||
| Capsugel Healthcare Private Limited | ₹340.69 Cr (FY 2025) | 9.0% | Gurugram, Haryana, India | |||
| Walter Bushnell Enterprises Private Limited | ₹340.47 Cr (FY 2025) | 132.0% | Mumbai, Maharashtra, India | |||
| Ozone Pharmaceuticals Limited | ₹337.45 Cr (FY 2025) | -1.0% | New Delhi, Delhi, India | |||
| Titan Laboratories Private Limitedthis company | ₹332.25 Cr (FY 2025) | ₹57.22 Cr | 17.2% | 305 | Mumbai, Maharashtra, India | |
| Sainor Laboratories Private Limited | ₹328.35 Cr (FY 2025) | -34.0% | Hyderabad, Telangana, India | |||
| Softgel Healthcare Private Limited | ₹327.36 Cr (FY 2025) | 42.0% | Puduppakkam, Tamil Nadu, India | |||
| Overseas Health Care Private Limited | ₹323.03 Cr (FY 2025) | 22.0% | Punjab, India | |||
| Gopaldas Visram and Company Limited | ₹322.71 Cr (FY 2025) | 15.0% | Mumabi, Maharashtra, India |
To see the full peer comparison of Titan Laboratories Private Limited, buy the company report.
Auditor
Titan Laboratories Private Limited is audited by RAJESH J SHAH & ASSOCIATES for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESH J SHAH & ASSOCIATES | FY 2025 | 108407W |
Shareholding
The shareholding of Titan Laboratories Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Titan Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹79.6 Cr
Satisfied charges
₹11.43 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Jan 2023 | 100668725 | Others | ₹20 Lakh | Open | |
| 06 Jan 2023 | 100668733 | Others | ₹20 Cr | Open | |
| 16 Jan 2020 | 100316164 | Others | ₹7.2 Cr | Open | |
| 01 Oct 2014 | 10527695 | The Ratnakar Bank Limited | ₹3.25 Cr | Open | |
| 22 Aug 2014 | 10517240 | Others | ₹23.1 Cr | Open |
To see the full charge records of Titan Laboratories Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Titan Laboratories Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹89.1 Lakh; the latest was in March 2024.
Total deals
3
Secondary share transfers
2
Funding round
1
Disclosed funding
₹89.1 Lakh
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Jan 2015 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2007 | Funding round | ₹89.1 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Titan Laboratories Private Limited has 22 court cases on record: 8 filed by Titan Laboratories, 14 filed against it. 4 cases are pending and 18 are disposed.
Total cases
22
Filed by the company
8
Filed against the company
14
Pending
4
Disposed
18
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 8 | 0 |
| High courts | 10 | 4 | 4 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (APEAL) | Filed by the company against M/S. Gena Pharmaceuticals Ltd. and Ors | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Gena Pharmaceuticals Ltd. | Disposed |
| Bombay High Court | Court case (ALP) | Filed by the company against M/S. Gena Pharmaceuticals Ltd and Ors | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Cases SS) | Filed by the company against M-S. Gena Pharmaceuticals Ltd and 2 Ors. | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by Prinicipal Commissioner of Income Tax 6 Mumbai | Pending |
To see the full case history of Titan Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Titan Laboratories Private Limited was last rated by Care on 07 Apr 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Apr 2022 |
To see the full credit ratings and regulatory alerts of Titan Laboratories Private Limited, buy the company report.
MSME payment delays
Titan Laboratories Private Limited has 3 MSME Form 1 returns on record between 2019 and 2023, listing 64 overdue payments to 48 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 48)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ankit Pulps and Boards Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Agarwal Life Sciences Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Titan Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Titan Laboratories has 1 subsidiary company. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Titan Pharmaplus Private Limited | U51397MH2022PTC378007 |
To see the full group structure of Titan Laboratories Private Limited, buy the company report.
Employees & EPFO
Titan Laboratories Private Limited has a workforce of 305 employees on its EPFO records as of Oct 07, 2025, across 1 active EPFO establishment.
Employee count
305
Active EPFO establishments
1
Employee growth
2.35%
GST
Titan Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCT0509Q1Z2 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Titan Laboratories Private Limited, buy the company report.
Recent activity
Titan Laboratories Private Limited has 7 board changes on record since 2004: 2 appointments and 5 cessations. The latest: Bhailal Babulal Shah ceased to be Whole-Time Director on 23 Dec 2021.
AGM
Titan Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Titan Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Others of Rs. 20.00 Cr registered on 06 Jan 2023 with Charge ID 100668733 was modified on 12 Jun 2024.
Charges
A charge with Others of Rs. 23.10 Cr registered on 22 Aug 2014 with Charge ID 10517240 was modified on 23 Mar 2023.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100668725 was registered on 06 Jan 2023.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100668733 was registered on 06 Jan 2023.
Charges
A charge with Others of Rs. 25.85 Cr registered on 22 May 2013 with Charge ID 10429702 was modified on 17 Feb 2022.
Ceased
Bhailal Babulal Shah ceased to be Whole-Time Director.
Ceased
Hiromi Deepak Shah ceased to be Whole-Time Director.
Ceased
Virendra Babulal Shah ceased to be Director.
Charges
A charge with Others amounted to Rs. 7.20 Cr with Charge ID 100316164 was registered on 16 Jan 2020.
Charges
A charge with The Ratnakar Bank Limited amounted to Rs. 3.25 Cr with Charge ID 10527695 was registered on 01 Oct 2014.
22 earlier events are in the company report.
Frequently asked questions
Titan Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2004 (22+ years old) and is registered under CIN U24100MH2004PTC146928.
Titan Laboratories has 2 current directors:
- Piyush Bhailal Shah - Managing Director
- Deepak Bhailal Shah - Whole-Time Director
The latest financial statements of Titan Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Titan Laboratories is 27AACCT0509Q1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Titan Laboratories is U24100MH2004PTC146928. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Titan Laboratories has 22 court cases on record: 8 filed by the company and 14 filed against it. 4 are pending. Most are in the district courts.
Titan Laboratories was incorporated on 14 June 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Titan Laboratories has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹89.1 Lakh; the latest was in March 2024.
The peers of Titan Laboratories by revenue are Geno Pharmaceuticals Private Limited, Sparsh Bio-Tech Private Limited, Capsugel Healthcare Private Limited, Walter Bushnell Enterprises Private Limited, Ozone Pharmaceuticals Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhailal Babulal Shah ceased to be Whole-Time Director on 23 Dec 2021. Hiromi Deepak Shah ceased to be Whole-Time Director on 23 Dec 2021. Virendra Babulal Shah ceased to be Director on 24 Apr 2020. Titan Laboratories has 7 board changes on record in total.
Yes, Titan Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0027850).
Titan Laboratories has 3 MSME Form 1 returns on record between 2019 and 2023, listing 64 overdue payments to 48 micro and small suppliers. The latest return was filed on 29 Aug 2023.